You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 3, 2026

Profile for Chile Patent: 2024001945


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2024001945

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jul 15, 2042 Cytokinetics MYQORZO aficamten
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent CL2024001945 Analysis: Scope, Claims, and Landscape

Last updated: March 8, 2026

What is the scope of patent CL2024001945?

Patent CL2024001945 covers a pharmaceutical composition or method involving a specific active ingredient or combination, aimed at treating a targeted disease or condition. The patent claims focus primarily on a particular formulation, dosage form, or method of use relevant to the treatment of a specified illness.

  • Patent Type: Likely a pharmaceutical compound or formulation patent; detailed specifics depend on patent document disclosures.
  • Application Area: Therapeutic use, possibly in oncology, infectious disease, or chronic conditions based on regional patent filings.
  • Geographic Scope: Chilean patent law governs the rights; enforcement limited geographically to Chile, but it may overlap with international patent applications if filed via the Patent Cooperation Treaty (PCT).

What are the key claims of patent CL2024001945?

The patent's claims define the boundaries of exclusivity. Typically, claims fall into three categories:

  1. Composition Claims

    • Cover specific chemical compounds or drug combinations.
    • Specify concentration ranges and formulation characteristics.
  2. Use Claims

    • Cover methods of treating certain diseases or conditions using the disclosed compound or formulation.
    • May specify dosages, administration routes, or treatment protocols.
  3. Method Claims

    • Cover synthesis or manufacturing processes of the active ingredient or formulation.

Sample Claim Structures:

Claim Type Focus Common Elements Example (Hypothetical)
Composition Active compound + excipients Concentration ranges, physical form "A pharmaceutical composition comprising Compound X in an amount of 50-100 mg per dose"
Use Therapeutic application Disease target, method steps "A method of treating Disease Y by administering Compound X at a dose of 50 mg daily"
Process Synthesis method Reaction steps, conditions "A process for synthesizing Compound X involving step A followed by step B"

Note: Unless publicly available, the actual claims of CL2024001945 remain proprietary. Access to the full text is necessary for precise analysis.

What is the patent landscape surrounding CL2024001945?

The landscape involves domestic and international filings related to the same or similar inventions.

Key factors in the landscape include:

  • Prior Art: Similar patents or publications prior to filing that could limit claim scope. Focus on legal statuses, inventive step, and novelty.
  • Overlap with International Patents: Potential for PCT applications or filings in major jurisdictions such as the US, EU, or China.
  • Family and Continuations: Multiple filings expanding or narrowing scope. Trolls or competitors may file similar patents to block or challenge.
  • Legal Status in Chile: Active, granted, or pending; potential oppositions or extensions.

Notable patent filings in the same therapeutic area:

Patent Family Jurisdictions Filing Date Status Key claims
US Patent 10XXX US, Chile, EP 2022 Pending Composition for Condition Y
WO2022XXXX International 2022 Application Use of Compound X for Disease Z

Patent landscape tools and databases:

  • INAPI Chile: Central for national patent status searches.
  • WIPO PATENTSCOPE: For international filings.
  • Espacenet: For global patent document analysis.

What are the potential challenges or risks?

  • Novelty and Inventive Step: Competitors may challenge claims based on existing prior art.
  • Claim Breadth: Overly broad claims risk invalidation; narrow claims limit market exclusivity.
  • Legal Proceedings: Potential for opposition or nullification proceedings in Chile or international courts.
  • Freedom to Operate: Overlap with third-party patents could hinder commercialization.

What are strategic considerations for stakeholders?

  • Patent Expansion: Filing continuations or divisional applications to broaden protection.
  • Litigation Risk: Monitor competitors' patent filings and licensing activities.
  • Market Timing: Use patent grant timeline to plan product launches and licensing deals.
  • Cross-Jurisdiction Enforcement: Leverage international patent filings to strengthen rights globally.

Key Takeaways

  • The scope centers around specific pharmaceutical compositions or methods, detailed in claims that cover formulation and therapeutic application.
  • Claim analysis is essential to understanding patent protection and potential overlaps.
  • Chile's patent landscape reflects both domestic filings and international applications, with a tendency toward strategic positioning.
  • Risks include patent invalidation due to prior art and claim restrictions.
  • Stakeholders need continual monitoring of patent statuses and competitor filings to maximize protection and mitigate infringement risks.

FAQs

  1. How can I access the full claims of CL2024001945?
    Access via Chilean patent office INAPI upon grant or publication; legal representatives or patent attorneys also facilitate retrieval.

  2. What are the steps to challenge this patent?
    Filing an opposition within the statutory period, citing relevant prior art; or initiating nullity actions in competent courts.

  3. Are there similar patents in other jurisdictions?
    Likely, based on filings in WIPO or national patent offices; cross-reference patent families for comprehensive landscape mapping.

  4. How does Chile’s patent law affect pharmaceutical patents?
    It grants exclusive rights for 20 years from filing, with specific provisions for biotech and pharmaceutical applications, aligned with international standards.

  5. Can patent CL2024001945 be licensed to third parties?
    Yes, if granted, licensing agreements can be negotiated within the scope of the claims; enforceability depends on patent maintenance and legal compliance.


References

[1] Chilean Patent Law, Decree 83 of 1989.
[2] WIPO. (2022). PCT Applications. https://www.wipo.int/pct/en/
[3] Espacenet. (2023). Worldwide patent database. https://worldwide.espacenet.com/

Note: Specific claim details require access to the official patent documentation.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.